Sector News

SRF acquires DuPont’s pharma propellant business Dymel for $20M

January 4, 2015
Energy & Chemical Value Chain
DuPont will supply SRF the product from its existing facility till SRF’s facility is approved.
 
Speciality chemicals firm SRF Ltd has acquired US-based E.l. DuPont De Nemours and Company (DuPont’s) pharma propellant business including the brand Dymel for $20 million (Rs 128 crore) in cash, as per a stock market disclosure.
 
Dymel provides a non-ozone depleting alternative propellant for use in the pharma industry. This business is part of the performance chemicals segment which DuPont anticipates separating by mid-2015.
 
Post acquisition, SRF will own DuPont’s ‘Dymel’ brand and receive the technology and know-how for setting up its own ‘current good manufacturing practices’ (cGMP) facility for manufacturing HFC 134a Pharma grade.
 
DuPont will supply SRF the product from its existing facility till SRF’s facility is approved.
 
“This acquisition is in sync with our long term strategy to move up the value chain and will enable us to enter the niche pharma product segment. The growth in the Metered Dose Inhalers (MDI) sector is expected to be reasonably robust in the years to come and with India playing a major role in this sector we are ideally positioned to take benefit of this opportunity. This will also offer great synergy with our existing HFC plants going forward,” said Ashish Bharat Ram, managing director of SRF.
 
“DuPont is making this move to enable a stronger focus on developing and commercializing the company’s new family of products. We believe this business is an excellent fit for SRF, which already supplies to the pharmaceutical industry,” said Kathryn K. McCord, global business director, DuPont Fluorochemicals.
 
Dymel also has applications in consumer and other industries. That line of the product is not part of this transaction.
 
Established in 1970, SRF is the one of the only Indian manufacturers of the grade of hydro fluoro carbon HFC 134a. For SRF, this transaction provides immediate access to DuPont’s technology, brand and customers, thus enabling an instant entry into the niche pharmaceutical segment at a global level.
 
SRF is engaged in the manufacture of chemical based industrial intermediates. Its business portfolio covers technical textiles, fluorochemicals, specialty chemicals, packaging films and engineering plastics. It has two plants for manufacture of technical grade of HFC 134a.
 
By Bhawna Gupta
 
Source: VC Circle

comments closed

Related News

December 6, 2024

Ineos Enterprises sells Ineos Composites for €1.7 Billion

Energy & Chemical Value Chain

Ineos Composites is a global manufacturer of unsaturated polyester resins, vinyl ester resins, and gelcoats used in plastic composites for a wide range of applications. The business has combined sales of more than €800 million annually and employs ~900 employees across 17 sites and 3 technology centers in Europe, North and South America, Asia, and the Middle East.

December 6, 2024

Dow appoints Karen S. Carter as Chief Operating Officer

Energy & Chemical Value Chain

Karen S. Carter will be responsible for driving business and operational performance across the organization with a focus on strengthening customer engagement and relationships, accelerating the commercialization of Dow’s innovation pipeline, and enhancing the Company’s reliability and service to customers.

December 6, 2024

Katja Wodjereck appointed Chief Commercial Officer of Vioneo

Energy & Chemical Value Chain

Katja Wodjereck most recently served at Neste, where she joined as Executive Vice President of the Renewable Road Transportation division in April 2023 and was later appointed Executive Vice President of Renewable Products in November 2023.

How can we help you?

We're easy to reach